EXHIBIT 2.

Drug Company–Sponsored Prescription Drug Access Programs For The Ten Top-Selling Medications In The United States In 2006

Drug	Type of benefit	Income eligibility	Can have other insurance?	Fees or copays required	No. of other drugs covered by program
Lipitor	PAP	Undisclosed	No	Zero	62
	Pharmacy card	No guidelines	No	Zeroa	97
Nexium	PAP	<300% of poverty	No	Zero	13
	PAP	<300% of poverty	Yesb	Zero	13
Advair Diskus	PAP	<250% of poverty, spent >$600 on Part D in calendar year	Yesb	Zero	50
	PAP	<250% of poverty	No	$10	50
Aranesp	PAP	<750% of poverty	No	Zero	5
Prevacid	PAP	<300% of poverty	Yes	Zero	0
Epogen	PAP	<750% of poverty	No	Zero	5
Zocor	–c	–c	–c	–c	–c
Enbrel	PAP	Undisclosed	Yes	Zero	0
Seroquel	PAP	<300% of poverty	No	Zero	13
	PAP	<300% of poverty	Yesb	Zero	13
Singulair	Pharmacy card	<200% of poverty	Yes	Zerod	9
	PAP	<200% of poverty	Yes	Zero	11

SOURCES: List of top-selling drugs obtained from IMS Health (see Note 10 in text). Other information derived from authors’ survey of drug company–sponsored pharmacy assistance programs (PAPs), 2007.

NOTES: PAP is patient assistance program. FPL is federal poverty level.

^aPatients pay 70–85 percent of retail price with discount card.

^bFor Medicare beneficiaries only.

^cNot applicable; Zocor is available as a generic, so it is not covered by the programs.

^dPatients pay 80–85 percent of retail price with discount card.